1. Home
  2. CGTX vs SILC Comparison

CGTX vs SILC Comparison

Compare CGTX & SILC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CGTX
  • SILC
  • Stock Information
  • Founded
  • CGTX 2007
  • SILC 1987
  • Country
  • CGTX United States
  • SILC Israel
  • Employees
  • CGTX N/A
  • SILC N/A
  • Industry
  • CGTX Biotechnology: Pharmaceutical Preparations
  • SILC Computer Manufacturing
  • Sector
  • CGTX Health Care
  • SILC Technology
  • Exchange
  • CGTX Nasdaq
  • SILC Nasdaq
  • Market Cap
  • CGTX 79.3M
  • SILC 86.9M
  • IPO Year
  • CGTX 2021
  • SILC 1994
  • Fundamental
  • Price
  • CGTX $0.44
  • SILC $14.53
  • Analyst Decision
  • CGTX Buy
  • SILC Hold
  • Analyst Count
  • CGTX 6
  • SILC 1
  • Target Price
  • CGTX $8.00
  • SILC N/A
  • AVG Volume (30 Days)
  • CGTX 476.7K
  • SILC 15.0K
  • Earning Date
  • CGTX 11-13-2024
  • SILC 10-31-2024
  • Dividend Yield
  • CGTX N/A
  • SILC N/A
  • EPS Growth
  • CGTX N/A
  • SILC N/A
  • EPS
  • CGTX N/A
  • SILC N/A
  • Revenue
  • CGTX N/A
  • SILC $62,386,000.00
  • Revenue This Year
  • CGTX N/A
  • SILC N/A
  • Revenue Next Year
  • CGTX N/A
  • SILC $4.15
  • P/E Ratio
  • CGTX N/A
  • SILC N/A
  • Revenue Growth
  • CGTX N/A
  • SILC N/A
  • 52 Week Low
  • CGTX $0.34
  • SILC $11.35
  • 52 Week High
  • CGTX $2.95
  • SILC $19.04
  • Technical
  • Relative Strength Index (RSI)
  • CGTX 41.17
  • SILC 58.09
  • Support Level
  • CGTX $0.43
  • SILC $13.61
  • Resistance Level
  • CGTX $0.48
  • SILC $14.40
  • Average True Range (ATR)
  • CGTX 0.04
  • SILC 0.54
  • MACD
  • CGTX -0.01
  • SILC 0.02
  • Stochastic Oscillator
  • CGTX 7.26
  • SILC 74.31

About CGTX Cognition Therapeutics Inc.

Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.

About SILC Silicom Ltd

Silicom Ltd designs and manufactures networking and data infrastructure solutions for various servers, server-based systems, and communications devices. Its product categories consist of Server Adapters; Edge Networking Solutions; FPGA Based Cards; x86 Open Appliances Bypass Switches and TAPs. Geographically, it derives a majority of its revenue from North America and also has a presence in Europe and Asia-Pacific.

Share on Social Networks: